Endocrine disruptors and prostate cancer risk

Endocrine-Related Cancer

Volumn 15, Issue 3, 2008, Pages 649-656

  Prins, Gail S ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHYLENE; ARSENIC; CADMIUM; CHLORPHENOTANE; CYTOCHROME P450 1A2; CYTOCHROME P450 3A4; DIETHYLSTILBESTROL; ESTROGEN; PESTICIDE; POLYCHLORINATED BIPHENYL; VINCLOZOLIN;

AGING; AGRICULTURAL WORKER; ARTICLE; BIOACCUMULATION; CANCER GROWTH; CANCER RISK; CELL LEVEL; CHEMICAL CARCINOGENESIS; DISEASE PREDISPOSITION; ENDOPLASMIC RETICULUM; ENVIRONMENTAL EXPOSURE; HUMAN; INTOXICATION; NONHUMAN; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; POLLUTANT; POPULATION RISK; PROSTATE CANCER; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; STEROID METABOLISM;

AGRICULTURE; ANDROGEN ANTAGONISTS; ENDOCRINE DISRUPTORS; ENVIRONMENTAL EXPOSURE; HUMANS; MALE; PESTICIDES; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 53849106806     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/ERC-08-0043     Document Type: Article

References (74)

1. Alavanja MC, Samanic C, Dosemeci M, Lubin J, Tarone R, Lynch CF, Knott C, Thomas K, Hoppin JA, Barker J et al. 2003 Use of agricultural pesticides and prostate cancer risk in the Agricultural Health Study cohort. American Journal of Epidemiology 157 800-814.
2. Anway M & Skinner M 2008 Transgenerational effects of the endocrine disruptor vinclozolin on the prostate transcriptome and adult onset disease. Prostate 68 515-529.
3. Anway MD, Cupp AS, Uzumcu M & Skinner MK 2005 Epigenetic trans generational actions of endocrine disuptors and mate fertility. Science 308 1466-1469.
4. Arai Y, Mori T, Suzuki Y & Bern HA 1983 Long-term effects of perinatal exposure to sex steroids and diethylstilbestrol on the reproductive system of male mammals. In International Review of Cytology, pp 235-268. Ed GHADJF Bourne. New York: Academic Press, Inc.
5. Benbrahim-Tallaa L & Waalkes MP 2008 Inorganic arsenic and human prostate cancer. Environmental Health Perspectives 116 158-164.
6. Benbrahim-Tallaa L, Webber MM & Waalkes MP 2007a Mechanisms of acquired androgen independence during arsenic-induced malignant transformation of human prostate epithelial cells. Environmental Health Perspectives 115 243-247.
7. Benbrahim-Tallaa L, Liu J, Webber MM & Waalkes MP 2007b Estrogen signaling and disruption of androgen metabolism in acquired androgen-independence during cadmium carcinogenesis in human prostate epithelial cells. Prostate 67 135-145.
8. Calafat AM, Ye X, Wong LY, Reidy JA & Needham LL 2008 Exposure of the US population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environmental Health Perspectives 116 39-44.
9. Charles LE, Loomis D, Shy CM, Newman B, Millikan R, Nylander-French LA & Couper D 2003 Electromagnetic fields, polychlorinated biphenyls, and prostate cancer mortality in electric utility workers. American Journal of Epidemiology 157 683-691.
10. Chen CJ, Kuo T & Wu M 1988 Aresenic and cancers. Lancet 1 414-415.
11. Cillo F, de Eguileor M, Gandolfi F & Brevini T 2007 Aroclor-1254 affects mRNA polyadenylation, translational activation, cell morphology, and DNA integrity of rat primary prostate cells. Endocrine-Related Cancer 14 257-266.
12. Davey JC, Bodwell JE, Gosse JA & Hamilton J 2007 Arsenic as an endocrine disruptor: effects of arsenic on estrogen receptor-mediated gene expression in vivo and in cell culture. Toxicological Sciences 98 75-86.
13. Driscoll SG & Taylor SH 1980 Effects of prenatal maternal estrogen on the male urogenital system. Obstetrics and Gynecology 56 537-542.
14. Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G, Nordenskjold M & Gustafsson J 1997 Human estrogen receptor β-gene structure, chromosomal localization, and expression pattern. Journal of Clinical Endocrinology and Metabolism 82 4258-4265.
15. Finnström N, Bjelfman C, Söderström T, Smith G, Egevad L, Norlén B, Wolf CR & Rane A 2001 Detection of cytochrome P450 mRNA transcripts in prostate samples by RT-PCR. European Journal of Clinical Investigation 31 880-886.
16. Giusti RM, Iwamoto K & Hatch EE 1995 Diethylstilbestrol revisited: a review of the long-term health effects. Annals of Internal Medicine 122 778-788.
17. Gray LE, Wolf C, Lambright C, Mann P, Price M, Cooper RL & Ostby J 1999 Administration of potentially antiandrogenic pesticides (procymidone, linuron, iprodione, chlozolinate, p,p′-DDE, and ketoconazole) and toxic substances (dibutyl- and diethylhexyl phthalate, PCB 169, and ethane dimethane sulphonate) during sexual differentiation produces diverse profiles of reproductive malformations in the male rat. Toxicology and Industrial Health 15 94-118.
18. Hardell L, Andersson SO, Carlberg M, Bohr L, van Bavel B, Lindström G, Björnfoth H & Ginman C 2006 Adipose tissue concentrations of persistent organic pollutants and the risk of prostate cancer. Journal of Occupational and Environmental Medicine 48 700-707.
19. Henderson BE, Bernstein L. Ross RK, Depue RH & Judd HL 1988 The early in utero oestrogen and testosterone environment of blacks and whites: potential effects on male offspring. British Journal of Cancer 57 216-218.
20. Henderson BE, Ross RK & Pike MC 1991 Toward the primary prevention of cancer. Science 254 1131-1136.
21. Ho SM, Tang WY, Belmonte J & Prins GS 2006 Developmental exposure estradiol and bisphenol A (BPA) increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodisesterase type 4 variant (PDE4D4) in the rat prostate. Cancer Research 66 5624-5632.
22. Hofkamp L, Bradley S, Tresguerres J, Lichtensteiger W, Schumpf M & Timms B 2008 Region-specific growth effects in the developing rat prostate following developmental exposure to estrogenic UV filters. Environmental Health Perspectives [in press].
23. Huang L, Pu Y, Alam S, Birch L & Prins GS 2004 Estrogenic regulation of signaling pathways and homeobox genes during rat prostate development. Journal of Andrology 25 330-337.
24. Huggins C & Hodges CF 1941 Studies on prostatic cancer. I. The effect of castration, of estrogen, and of androgen injection on serum phosphatases in metastic carcinoma of the prostate. Cancer Research 1 293-297.
25. Jarred RA, Keikha M, Dowling C, McPherson SJ, Clare AM, Husband AJ, Pedersen JS, Frydenberg M & Risbridger GP 2002 Induction of apoptosis in low to moderate-grade human prostate carcinoma by red clover-derived dietary isoflavones. Cancer Epidemiology, Biomarkers and Prevention 11 1689-1696.
26. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T & Thun MJ 2008 Cancer Statistics, 2008. CA: A Cancer Journal for Clinicians 58 71-96.
27. Kaufman JM & Vermeulen A 2005 The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocrine Reviews 26 833-876.
28. Kavlok R & Cummings A 2005 Mode of action: inhibition of androgen receptor function - vinclozolin-induced malformations in reproductive development. Critical Revievvs in Toxicology 35 721-726.
29. Keri R, Ho SM, Hunt PA, Knudsen KE, Soto AM & Prins GS 2007 An evaluation of evidence for the carcinogenic activity of bisphenol A: report of NIEHS Expert Panel on BPA. Reproductive Toxicology 24 240-252.
30. Kester MH, Bulduk S, Tibboel D, Meinl W, Glatt H, Falany CN, Coughtrie MW, Bergman A, Safe SH, Kuiper GG et al. 2000 Potent inhibition of estrogen sulfotransferase by hydroxylated PCB metabolites: a novel pathway explaining the estrogenic activity of PCBs. Endocrinology 141 1897-1900.
31. Kester MH, Bulduk S, van Toor H, Tibboel D, Meinl W, Glatt H, Falany CN, Coughtrie MW, Schuur AG, Brouwer A et al. 2002 Potent inhibition of estrogen sulfotransferase by hydroxylated metabolites of polyhalogenated aromatic hydrocarbons reveals alternative mechanism for estrogenic activity of endocrine disrupters. Journal of Clinical Endocrinology and Metabolism 87 1142-1150.
32. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B & Gustafsson JA 1998 Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139 4252-4263.
33. Kurosawa T, Hiroi H, Tsutsumi O, Ishikawa T, Osuga Y, Fujiwara T, Inoue S, Muramatsu M, Momoeda M & Taketani Y 2002 The activity of bisphenol A depends on both the estrogen receptor subtype and the cell type. Endocrine Journal 49 465-471.
34. Lakshman M, Xu L, Ananthanarayanan V, Cooper J, Takimito CH, Helenowski I, Pelling JC & Bergan RC 2008 Dietary genistein inhibits metastasis of human prostate cancer in mice. Cancer Research 68 2024-2032.
35. Lawson T & Kolar C 2002 Human prostate epithelial cells metabolize chemicals of dietary origin to mutagens. Cancer Letters 175 141-146.
36. Leav I, Ho S, Ofner P, Merk F, Kwan P & Damassa D 1988 Biochemical alterations in sex hormone-induced hyperplasia and dysplasia of the dorsolateral prostates of Noble rats. Journal of National Cancer Institute 80 1045-1053.
37. Lemmen JG, Arends RJ, van der Saag PT & van der Burg B 2004 In vivo imaging of activated estrogen receptors in utero by estrogens and bisphenol A. Environmental Health Perspectives 112 1544-1549.
38. Lewis DR, Southwick JW, Ouellet-Hellstrom R, Rench J & Calderon R 1999 Drinking water aresenic in Utah: a cohort mortality study. Enviromnental Health Perspectives 107 359-365.
39. Lo S, King I, Aflléra A & Klingmüller D 2007 Effects of various pesticides on human 5alpha-reductase activity in prostate and LNCaP cells. Toxicology In Vitro 21 502-508.
40. Van Maele-Fabry G, Libotte V, Willems J & Lison D 2006 Review and meta-analysis of risk estimates for prostate cancer in pesticide manufacturing workers. Cancer Causes & Control 17 353-373.
41. Mahajan R, Bonner MR, Hoppin JA & Alavanja MC 2006 Phorate exposure and incidence of cancer in the agricultural health study. Environmental Health Perspectives 114 1205-1209.
42. McCormick DL, Johnson WD, Bosland MC, Lubet RA & Steele VE 2007 Chemoprevention of rat prostate carcinogenesis by soy isoflavones and by Bowman-Birk inhibitor. Nutrition and Cancer 57 184-193.
43. Meyer TE, Coker AL, Sanderson M & Symanski E 2007 A case-control study of farming and prostate cancer in African-American and Caucasian men. Occupational and Environmental Medicine 64 155-160.
44. Modugno F, Weissfeld JL, Trump DL, Zmuda JM, Shea P, Cauley JA & Ferrell RE 2001 Allelic variants of aromatase and androgen and estrogen receptors: toward a multigenic model of prostate cancer risk. Clinical Cancer Research 7 3092-3096.
45. Moore RA 1947 In Endocrinology of Neoplastic Disease, p. 194. New York: Oxford University Press.
46. Morrison H, Savitz D, Semenciw R, Hulka B, Mao Y, Morison D & Wigle D 1993 Farming and prostate cancer mortality. American Journal of Epidemiology 137 270-280.
47. Nelson WG, DeWeese TL & DeMarzo AM 2002 The diet, prostate inflammation, and the development of prostate cancer. Cancer Metastasis Reviews 21 3-16.
48. Parent ME & Siemiatycki J 2001 Occupation and prostate cancer. Epidemiology Reviews 23 138-143.
49. Prince MM, Ruder AM, Hein MJ, Waters MA, Whelan EA, Nilsen N, Ward EM, Schnorr TM, Laber PA & Davis-King KE 2006 Mortality and exposure response among 14 458 electrical capacitor manufacturing workers exposed to polychlorinated biphenyls (PCBs). Environmental Health Perspectives 114 1508-1514.
50. Prins GS & Birch L 1997 Neonatal estrogen exposure up-regulates estrogen receptor expression in the developing and adult rat prostate lobes. Endocrinology 138 1801-1809.
51. Prins GS & Korach KS 2008 The role of estrogens and estrogen receptors in normal prostate growth and disease. Steroids 73 233-244.
52. Prins GS, Marmer M, Woodham C, Chang WY, Kuiper G, Gustafsson JA & Birch L 1998 Estrogen receptor-β messenger ribonucleic acid ontogeny in the prostate of normal and neonatally estrogenized rats. Endocrinology 139 874-883.
53. Prins GS, Birch L, Habermann H, Chang WY, Tebeau C, Putz O & Bieberich C 2001 Influence of neonatal estrogens on rat prostate development. Reproduction, Fertility, and Developinent 13 241-252.
54. Prins GS, Birch L, Yang WY & Ho SM 2007 Developmental estrogen exposures predispose to prostate carcinogenesis with aging. Reproductive Toxicology 23 374-382.
55. Prins GS, Tang WY, Belmonte J & Ho SM 2008 Perinatal exposure to oestradiol and bisphenol A alters the prostate epigenome and increases susceptibility to carcinogenesis. Basic Clinical Pharmacology & Toxicology 102 134-138.
56. Raghow S, Hooshdraran MZ, Katiyar S & Steiner MS 2002 Toremifene prevents prostate cancer in the transgenic adenocarcinorna of mouse prostate model. Cancer Research 62 1370-1376.
57. Rajfer J & Coffey DS 1978 Sex steroid imprinting of the immature prostate. Investigative Urology 16 186-190.
58. Ritchie JM, Vial SL, Fuortes LJ, Guo H, Reedy VE & Smith EM 2003 Organochlorines and risk of prostate cancer. Journal of Occupational and Environmental Medicine 45 692-702.
59. Schlumpf M, Jarry H, Wuttke W, Ma R & Lichtensteiger W 2004a Estrogenic activity and estrogen receptor beta binding of the UV filter 3-benzylidene camphor. Comparison with 4-methylbenzylidene camphor. Toxicology 199 109-120.
60. Schlumpf M, Schmid P, Durrer S, Conscience M, Maerkel K, Henseler M, Gruetter M, Herzog I, Reolon S, Ceccatelli R et al. 2004b Endocrine activity and developmental toxicity of cosmetic UV filters - an update. Toxicology 205 113-122.
61. Schulze H & Claus S 1990 Histological localization of estrogen receptors in normal and diseased human prostates by immunocytochemistry. Prostate 16 331-343.
62. Smith MR, Malkowicz SB, Chu F, Forrest J, Price D, Sieber P, Barnette KG, Rodriguez D & Steiner MS 2008 Toremifene increases bone mineral density in men receiving androgen deprivation therapy for prostate cancer: interim analysis of a multicenter phase 3. Journal of Urology 179 152-155.
63. Song KH, Lee K & Choi HS 2002 Endocrine disruptor bisphenol A induces orphan nuclear receptor Nur77 gene expression and steroidogenesis in mouse testicular Leydig cells. Endocrinology 143 2208-2215.
64. Steiner MS & Pound CR 2003 Phase IIA clinical trial to test the efficacy and safety of Toremifene in men with high-grade prostatic intraepithelial neoplasia. Clinical Prostate Cancer 2 24-31.
65. Sterling KM & Cutrineo KR 2004 Constitutive and inducible expression of cytochromes P4501A (CYPIA1 and CYPIA2) in normal prostate and prostate cancer cells. Journal of Cell Biology 91 423-429.
66. Usmani KA, Rose RL & Hodgson E 2003 Inhibition and activation of the human liver microsomal and human cytochrome P450 3A4 metabolism of testosterone by deployment-related chemicals. Drug Metabolism and Disposition 31 384-391.
67. Usmani KA, Cho TM, Rose RL & Hodgson E 2006 Inhibition of the human liver microsomal and human cytochrome P450 1A2 and 3A4 metabolism of estradiol by deployment-related and other chemicals. Drug Metabolism and Disposition 34 1606-1614.
68. Waalkes MP 2000 Cadmium carcinogenesis in review. Journal of Inorganic Biochemistry 79 241-244.
69. 2+]i in human breast cancer cells. Molecular and Cellular Endocrinology 230 23-30.
70. Watson WH & Yager JD 2007 Arsenic: extension of its endocrine disruption potential to interference with estrogen receptor-mediated signaling. Toxicological Sciences 98 1-2.
71. Wetherill YB, Fisher NL, Staubach A, Danielsen M, de Vere White RW & Knudsen KE 2005 Xenoestrogen action in prostate cancer: pleiotropic effects dependent on androgen receptor status. Cancer Research 65 54-65.
72. Wetherill YB, Hess-Wilson JK, Comstock CE, Shah SA, Buncher CR, Sallans L, Limbach PA, Schwemberger S, Babcock GF & Knudsen KE 2006 Bisphenol A facilitates bypass of androgen ablation therapy in prostate cancer. Molecular Cancer Therapeutics 5 3181-3190.
73. Yonemura CY, Cunha GR, Sugimura Y & Mee SL 1995 Temporal and spatial factors in diethylstilbestrol-induced squamous metaplasia in the developing human prostate. II. Persistent changes after removal of diethylstilbestrol. Acta Anatomica 153 1-11.
74. Yu W, Lee B, Nam S, Ahn B, Hong J, Do J, Kim Y, Lee Y & Yun Y 2004 Reproductive disorders in pubertal and adult phase of the male rats exposed to vinclozolin during puberty. Journal of Veterinary Medical Science 66 847-853.